Inspire – Study that will enroll subjects with a clinical diagnosis of COVID-19 confirmed by laboratory testing and who are in severe or critical condition as indicated by life-support measures.
Synairgen – A Randomized Double-blind Placebo-controlled Trial to Determine the Safety and Efficacy of Inhaled SNG001 (IFN-β1a for Nebulization) for the Treatment of Patients With confirmed SARS-CoV-2 Infection
Tonglian – Study of the safety and efficacy of carrimycin for treatment of severe COVID-19 in hospitalized patients.
Paraglide- A multicenter, randomized, double-blind, double-dummy, parallel group, active controlled study to evaluate the effect of sacubitril/valsartan (LCZ696) versus valsartan on changes in NT-proBNP and outcomes, safety, and tolerability in HFpEF patients with acute decompensated heart failure (ADHF) who have been stabilized during hospitalization and initiated in-hospital or within 30 days post-discharge (PARAGLIDE-HF)
AEGIS-II – Study to investigate CSL112 in subjects with acute coronary syndrome.
Pacific AMI – Study to gather information about the proper dosing and safety of the oral FXIa Inhibitor BAY 2433334 in patients following an acute heart attack
Heart-FID – Study to determine the efficacy and safety of iron therapy using intravenous (IV) ferric carboxymaltose (FCM), relative to placebo, in the treatment of participants in heart failure with iron deficiency and with a reduced ejection fraction.
BMAD – Study to assess investigator engagement of μCor system data in the context of heart failure management. The μCor system includes a sensor and wearable patch for fluid management.
Stride PAD– Effects of semaglutide on functional capacity in patients with type 2 diabetes and peripheral arterial disease
Empact MI– A streamlined, multicenter, randomized, parallel group, double-blind placebo-controlled superiority trial to evaluate the effect of Empagliflozin on hospitalization for heart failure and mortality in patients with Acute Myocardial Infarction
MAPS: The Arrhythmia Management System (AMS; ZOLL, Pittsburgh, PA) records rhythm, heart rate, subject-reported symptoms, and multiple parameters that include respiration rate, activity, and body posture (biometric data).
Ri-CoDIFy – Study to compare ridinilazole verses vancomycin in treatment of Clostridium difficile infection.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.